Cell-based gene therapies in oncology: Case study of the challenges of CAR-T therapy

• At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
• Type: Presentation
• By: KOLESAR, Jill (University of Kentucky, USA)
• Abstract:

  CAR T therapy is a type of treatment in which a patient's T cells are removed via apheresis, sent to a processing laboratory and a chimeric antigen receptor (CAR) is introduced into the T cells, which allows the CAR T cell to identify and eliminate both malignant and normal cells that express a given antigen.   While multiple tumor antigens are..

The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login